Skip to main content
SleepCited

Melatonin için Uykusuzluk

A

143 çalışmaya (13 meta-analyses, 15 RCTs), toplam 44,766 katılımcıyla dayanmaktadır. 92/143 çalışma olumlu etkiler göstermektedir.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmelatonin\u0026condition\u003Dinsomnia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Sonuç

Melatonin is supported by strong, extensive evidence as a supplement that may help with insomnia, making it one of the most well-researched natural sleep aids available.

  • 143 studies with 44,766 participants — among the largest evidence bases for any sleep supplement
  • 13 meta-analyses and 15 RCTs provide high-quality evidence
  • Recognized in multiple clinical practice guidelines and expert consensus statements
  • About 64% of studies show positive effects; results may vary by insomnia type and population

Key Study Findings

Other
A bedside-savior for insomnia and anxiety disorders: melatonin/buspirone hydrochloride compound oral fast-dissolving film.
Dose: melatonin + buspirone hydrochloride vs: None Outcome: product development for insomnia with anxiety Etki: None None

Popülasyon: patients with insomnia and anxiety disorders (formulation development)

review
Pediatric Insomnia.
Dose: Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) vs: Placebo Etki: CBT-I most effective treatment; melatonin beneficial in children with ASD or ADHD; limited evidence None
animal study
Compound Chaijin Jieyu Fang alleviates insomnia complicated with depression by reshaping actinobacteria to inhibit neuronal …
Dose: Compound Chaijin Jieyu Fang (CCJF) traditional Chinese medicine formula; dose not specified vs: Placebo Etki: None None
Observational Study n=55
Correlation between sleep problems and morning serum melatonin and ferritin levels in Japanese 5-year-old children …
Dose: None vs: None Outcome: correlation between sleep problems and morning serum melatonin … Etki: None p<0.05

Popülasyon: Japanese 5-year-old children (45 ASD, 10 non-ASD)

Controlled Clinical Trial n=24 2 weeks
D-Ribose-L-Cysteine protects against sodium arsenite-induced hepato-nephrotoxicity in rats.
Dose: 10 mg/kg body weight vs: Sodium arsenite group (SA, no riboceine) Outcome: Hepato-nephrotoxicity markers (ALT, AST, creatinine) Etki: None None

Popülasyon: Rats with sodium arsenite-induced toxicity

review
Delayed sleep-wake phase disorder.
Dose: Scheduled melatonin, scheduled sleep-wake times, bright light therapy vs: Placebo Etki: None None

Key Statistics

237

Çalışmalar

54266

Katılımcılar

Positive

A

Derece

Referenced Papers

Pediatrics in review 2026
Cleveland Clinic journal … 2025 12 atıf
Handbook of clinical … 2025 10 atıf
Chemico-biological interactions 2025 2 atıf
CNS spectrums 2025 1 atıf
JAAPA : official … 2025 1 atıf
Paediatrics & child … 2025
The Cochrane database … 2025
Biologie aujourd'hui 2025
The Psychiatric clinics … 2024 11 atıf
Sleep medicine 2024 6 atıf
La Revue du … 2024
Current neuropharmacology 2023 38 atıf
Journal of clinical … 2023 6 atıf
Sub-cellular biochemistry 2023 2 atıf
International journal of … 2022 107 atıf
Neurologia 2022 78 atıf
Archives of physiology … 2022 69 atıf
Neurologia 2022 47 atıf
Current neuropharmacology 2022 40 atıf
Journal of the … 2022 4 atıf
Annual review of … 2021 149 atıf
Progress in neuro-psychopharmacology … 2021 68 atıf
Child and adolescent … 2021 61 atıf
Chronobiology international 2021 47 atıf
Combinatorial chemistry & … 2021 16 atıf
Nutricion hospitalaria 2021 3 atıf
Neurotherapeutics : the … 2020 80 atıf
Journal of psychiatric … 2020 52 atıf
Current treatment options … 2020 29 atıf
Sleep medicine clinics 2020 27 atıf
The Medical letter … 2020 2 atıf
Journal of pineal … 2019 124 atıf
Journal of translational … 2019 93 atıf
Dermatitis : contact, … 2019 7 atıf
Journal of the … 2019 5 atıf
The Medical letter … 2019
Sexual medicine reviews 2018 74 atıf
Travel medicine and … 2018 27 atıf
Ugeskrift for laeger 2018 2 atıf
Nederlands tijdschrift voor … 2018
Neurological research 2017 331 atıf
Continuum (Minneapolis, Minn.) 2017 132 atıf
American family physician 2017 124 atıf
Current treatment options … 2017 56 atıf
Annual review of … 2016 557 atıf
Chest 2016 109 atıf
European heart journal. … 2016 77 atıf
Trends in endocrinology … 2016 36 atıf
Sleep medicine clinics 2015 75 atıf
Sleep medicine clinics 2015 30 atıf
Medwave 2015 6 atıf
Drug discovery today 2014 191 atıf
Child and adolescent … 2014 42 atıf
Current signal transduction … 2014 41 atıf
Anales de pediatria … 2014
Continuum (Minneapolis, Minn.) 2013 172 atıf
Profiles of drug … 2013 26 atıf
Journal of pineal … 2012 322 atıf
Expert opinion on … 2012 116 atıf
Expert opinion on … 2012 42 atıf
Pharmacological reports : … 2011 99 atıf
Expert opinion on … 2011 22 atıf
Anaesthesia and intensive … 2011 18 atıf
Journal of pineal … 2011
Expert review of … 2010 58 atıf
Current treatment options … 2010
Travel medicine and … 2009 101 atıf
Seminars in neurology 2009 17 atıf
Tidsskrift for den … 2009 6 atıf
Drug and therapeutics … 2009
Turk psikiyatri dergisi … 2009
Arzneimittel-Forschung 2008 89 atıf
Clinics in geriatric … 2008 53 atıf
The FEBS journal 2006 56 atıf
Seminars in neurology 2004 16 atıf
Journal of neuroendocrinology 2003 719 atıf
Maturitas 2002 59 atıf
Primary care 2002 43 atıf
Revista de neurologia 2002 35 atıf
Neuro endocrinology letters 2002
The Journal of … 2001 305 atıf
Zeitschrift fur arztliche … 2001 3 atıf
Journal of the … 2000 52 atıf
Medical science monitor … 2000 11 atıf
Reproduction, nutrition, development 1999 64 atıf
Biological signals and … 1999 48 atıf
Journal of the … 1999 24 atıf
Current treatment options … 1999 23 atıf
European journal of … 1999
Postgraduate medical journal 1998 17 atıf
American family physician 1997
Journal of sleep … 1996 95 atıf
Canadian journal of … 1984 22 atıf
Microbiology and immunology 1982 41 atıf

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
0.5-3 mg, 30-60 min before bed
jetlag:
0.5-5 mg

Üst sınır: No established UL; 5 mg typically considered maximum

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
melatonin + buspirone hydrochloride -- Neutral --
Melatonin (various doses), CBT-I (behavioral), pharmacologic options (z-drugs, other) -- Positive --
Compound Chaijin Jieyu Fang (CCJF) traditional Chinese medicine formula; dose not specified -- Positive --
None -- Positive 55
10 mg/kg body weight 2 weeks Positive 24
Scheduled melatonin, scheduled sleep-wake times, bright light therapy -- Positive --
None -- Mixed --
None -- Positive 51

En iyi alım zamanı: 30-60 minutes before bed

Safety & Side Effects

Bildirilen Yan Etkiler

  • Daytime drowsiness
  • Headache
  • Dizziness
  • Nausea
  • Vivid dreams or nightmares

Bilinen Etkileşimler

  • Blood thinners (warfarin) — may increase bleeding risk
  • Immunosuppressants — melatonin may stimulate immune function
  • Diabetes medications — may affect blood sugar levels
  • Sedatives and CNS depressants — additive drowsiness

Tolere edilebilir üst alım: No established UL; 5 mg typically considered maximum

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Melatonin help with Uykusuzluk?
Based on 237 studies with 54,266 participants, there is strong evidence from multiple clinical trials that Melatonin may support Uykusuzluk management. Our evidence grade is A (Strong Evidence).
How much Melatonin should I take for Uykusuzluk?
Studies have used various dosages. A commonly studied range is 0.5-3 mg, 30-60 min before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Melatonin?
Reported side effects may include Daytime drowsiness, Headache, Dizziness, Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Melatonin and Uykusuzluk?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 237 peer-reviewed studies with 54,266 total participants. The overall direction of effect is positive.

Related Evidence

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.